SHRESTH Index for Drug Regulation
On 12th August 2025, the Union Health Ministry launched the State Health Regulatory Excellence Index (SHRESTH) to benchmark and strengthen state drug regulatory systems through a transparent, data-driven framework.
- The initiative focuses on improving human resources, infrastructure, and digitisation in drug regulatory systems while promoting cross-learning and the adoption of best practices among states.
- Developed by the Central Drugs Standard Control Organisation (CDSCO) in consultation with states, the index will rank them in two categories — manufacturing states and primarily distribution states/UTs.
- Manufacturing states will be evaluated on 27 parameters across five themes — human resources, infrastructure, licensing, surveillance, and ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
India Watch
- 1 SC Upholds Reproductive Autonomy in Surrogacy Cases
- 2 SPARK-4.0: Nurturing Young Ayurveda Researchers Nationwide
- 3 Digital Monitoring of Rural Water and Sanitation Sector
- 4 Freedom of Religion and Right to Privacy Interlinked: Supreme Court
- 5 National Workshop on Communication and Dissemination of Indian Knowledge System for Teachers
- 6 India Maritime Week 2025
- 7 Supreme Court Extends ‘Public Trust Doctrine’ to Artificial Lakes
- 8 Constitutional Morality
- 9 MAHA MedTech Mission: Strengthening India’s Medical Technology Ecosystem
- 10 NITI Aayog Unveils Advanced Manufacturing Roadmap

